Capital Market Strategies LLC Has $524,000 Stake in Intuitive Surgical, Inc. $ISRG

Capital Market Strategies LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 965 shares of the medical equipment provider’s stock after selling 89 shares during the period. Capital Market Strategies LLC’s holdings in Intuitive Surgical were worth $524,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Chilton Capital Management LLC lifted its holdings in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares during the period. Global Financial Private Client LLC increased its stake in Intuitive Surgical by 253.3% in the first quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 38 shares in the last quarter. Elite Financial Inc. bought a new stake in Intuitive Surgical in the first quarter valued at $26,000. LFA Lugano Financial Advisors SA bought a new stake in Intuitive Surgical in the first quarter valued at $30,000. Finally, TD Capital Management LLC increased its stake in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at approximately $325,669.91. This represents a 31.19% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 45,224 shares of company stock valued at $21,716,492. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $449.68 on Friday. The firm has a 50-day moving average of $485.67 and a 200-day moving average of $508.71. The company has a market cap of $161.20 billion, a PE ratio of 62.72, a PEG ratio of 4.78 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the firm posted $1.78 EPS. The firm’s quarterly revenue was up 21.4% compared to the same quarter last year. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Truist Financial lifted their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. BTIG Research lifted their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Evercore ISI boosted their target price on shares of Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $595.95.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.